In the past week, HIMS stock has gone down by -3.04%, with a monthly gain of 19.40% and a quarterly plunge of -15.99%. The volatility ratio for the week is 6.57%, and the volatility levels for the last 30 days are 5.30% for Hims & Hers Health Inc The simple moving average for the last 20 days is 3.80% for HIMS’s stock, with a simple moving average of 14.27% for the last 200 days.
Is It Worth Investing in Hims & Hers Health Inc (NYSE: HIMS) Right Now?
The price-to-earnings ratio for Hims & Hers Health Inc (NYSE: HIMS) is 230.35x, which is above its average ratio. Moreover, the 36-month beta value for HIMS is 1.07. Analysts have varying opinions on the stock, with 3 analysts rating it as a “buy,” 2 as “overweight,” 8 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for HIMS is 173.82M and currently, short sellers hold a 15.27% of that float. On October 04, 2024, HIMS’s average trading volume was 8.41M shares.
HIMS) stock’s latest price update
Hims & Hers Health Inc (NYSE: HIMS) has experienced a rise in its stock price by 0.58 compared to its previous closing price of 17.13. However, the company has seen a fall of -3.04% in its stock price over the last five trading days. fastcompany.com reported 2024-10-04 that Shares of Hims & Hers Health fell almost 10% today following an announcement from the U.S. Food and Drug Administration (FDA) that competitor Eli Lilly’s obesity and diabetes drugs are no longer facing supply constraints, and have been removed from the shortage list.
Analysts’ Opinion of HIMS
Many brokerage firms have already submitted their reports for HIMS stocks, with Needham repeating the rating for HIMS by listing it as a “Buy.” The predicted price for HIMS in the upcoming period, according to Needham is $24 based on the research report published on August 22, 2024 of the current year 2024.
Citigroup gave a rating of “Neutral” to HIMS, setting the target price at $20 in the report published on May 22nd of the current year.
HIMS Trading at 2.58% from the 50-Day Moving Average
After a stumble in the market that brought HIMS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -33.06% of loss for the given period.
Volatility was left at 5.30%, however, over the last 30 days, the volatility rate increased by 6.57%, as shares surge +25.71% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -26.19% lower at present.
During the last 5 trading sessions, HIMS fell by -3.43%, which changed the moving average for the period of 200-days by +98.61% in comparison to the 20-day moving average, which settled at $16.77. In addition, Hims & Hers Health Inc saw 93.60% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HIMS starting from Dudum Andrew, who sale 188,888 shares at the price of $18.18 back on Oct 01 ’24. After this action, Dudum Andrew now owns 67,015 shares of Hims & Hers Health Inc, valued at $3,433,162 using the latest closing price.
Dudum Andrew, the Chief Executive Officer of Hims & Hers Health Inc, sale 144,444 shares at $18.22 during a trade that took place back on Oct 01 ’24, which means that Dudum Andrew is holding 651,046 shares at $2,631,394 based on the most recent closing price.
Stock Fundamentals for HIMS
Current profitability levels for the company are sitting at:
- 0.0 for the present operating margin
- 0.78 for the gross margin
The net margin for Hims & Hers Health Inc stands at 0.02. The total capital return value is set at 0.01. Equity return is now at value 5.31, with 4.16 for asset returns.
Based on Hims & Hers Health Inc (HIMS), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at 11.2. The debt to equity ratio resting at 0.03. The interest coverage ratio of the stock is 2.71.
Currently, EBITDA for the company is -23.95 million with net debt to EBITDA at -7.39. When we switch over and look at the enterprise to sales, we see a ratio of 3.24. The receivables turnover for the company is 192.24for trailing twelve months and the total asset turnover is 2.22. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.68.
Conclusion
To wrap up, the performance of Hims & Hers Health Inc (HIMS) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
